A new therapy for treating atrial fibrillation using low-energy stimulation.
Spatial Resynchronization Therapy for AFib
This study is exploring a new, gentler way to help people with atrial fibrillation by using a special device that sends low-energy signals to help restore a normal heartbeat, making treatment easier and more comfortable than current methods.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Maxwell Biomedical INC NIH-funded |
| Lab location | 1 site (San Diego, United States) |
| Project ID | NIH-10922069 on NIH RePORTER |
What this research studies
This research investigates a novel approach to treating atrial fibrillation (AF) through the use of the Spatial Resynchronization Therapy (SRT) System. The therapy aims to improve patient outcomes by utilizing spatiotemporal identification of the excitable gap in the heart and applying ultra-low energy stimulation to restore normal heart rhythm. This method seeks to address the limitations of current treatments, such as painful high-voltage shocks and variable success rates associated with catheter ablation. By focusing on a less invasive and more tolerable treatment option, the research aims to enhance the quality of care for patients suffering from AF.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with atrial fibrillation who may benefit from a less invasive treatment option.
Not a fit: Patients with other types of arrhythmias or those who are not candidates for atrial fibrillation treatment may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a safer and more effective treatment option for patients with atrial fibrillation, potentially reducing hospitalizations and improving quality of life.
How similar studies have performed: While the approach of using low-energy stimulation for AF treatment is innovative, similar methods have shown promise in preliminary studies, indicating potential for success.
Where this research is happening
San Diego, United States
- Maxwell Biomedical INC — San Diego, United States (Active)
Researchers
- Principal investigator: Beatty, Graydon Ernest — Maxwell Biomedical INC
- Study coordinator: Beatty, Graydon Ernest
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.